{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:37:18Z","timestamp":1792931838472,"version":"4.5.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>This session of the 2013 Society of Hematopathology\/European Association for Haematopathology workshop focused on extramedullary manifestations of myeloid neoplasms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>We divided the submitted cases into four subgroups: (1) isolated myeloid sarcoma (MS); (2) MS with concurrent acute myeloid leukemia (AML), with a focus on karyotypic and molecular findings; (3) extramedullary relapse of AML, including relapse in the posttransplant setting; and (4) blast phase\/transformation of a myeloproliferative neoplasm or chronic myelomonocytic leukemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Establishing a diagnosis of isolated MS requires a high index of suspicion and use of immunophenotypic methods. Recurrent cytogenetic abnormalities or gene mutations that occur in MS mirror those known to occur in AML.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>In the era of targeted therapy and sophisticated risk stratification, every attempt must be made to perform a complete workup on MS cases (or concurrent AML) since the diagnosis of MS, in itself, is no longer adequate for patient management. Cases of blastic plasmacytoid dendritic cell neoplasm were also included and discussed in this session.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcpo58ywibubesx","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T12:48:53Z","timestamp":1437050933000},"page":"219-239","source":"Crossref","is-referenced-by-count":110,"title":["Extramedullary Manifestations of Myeloid Neoplasms"],"prefix":"10.1093","volume":"144","author":[{"given":"Carla S.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"The Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,1]]},"reference":[{"key":"2021052713505415200_b1-1440219","first-page":"140","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th"},{"key":"2021052713505415200_b2-1440219","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"2021052713505415200_b3-1440219","first-page":"790","article-title":"Extramedullary myeloid cell tumors: an immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"2021052713505415200_b4-1440219","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2021052713505415200_b5-1440219","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/10428190601059803","article-title":"Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature","volume":"48","author":"Ramasamy","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"2021052713505415200_b6-1440219","first-page":"562","article-title":"Mediastinal granulocytic sarcoma: poor risk AML?","volume":"111","author":"Gogia","year":"2013","journal-title":"J Indian Med Assoc"},{"key":"2021052713505415200_b7-1440219","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children\u2019s Cancer Group","volume":"25","author":"Dusenbery","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021052713505415200_b8-1440219","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"2021052713505415200_b9-1440219","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2011.041418","article-title":"Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation","volume":"96","author":"Chevallier","year":"2011","journal-title":"Haematologica"},{"key":"2021052713505415200_b10-1440219","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2012.10.014","article-title":"Is there a \u201cgold\u201d standard treatment for patients with isolated myeloid sarcoma?","volume":"67","author":"Antic","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"2021052713505415200_b11-1440219","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni","year":"2011","journal-title":"Ther Adv Hematol"},{"key":"2021052713505415200_b12-1440219","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","article-title":"Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc+ AML): biologic and clinical features","volume":"109","author":"Falini","year":"2007","journal-title":"Blood"},{"key":"2021052713505415200_b13-1440219","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0002-9440(10)63052-0","article-title":"Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement","volume":"159","author":"Park","year":"2001","journal-title":"Am J Pathol"},{"key":"2021052713505415200_b14-1440219","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.leukres.2004.01.006","article-title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"key":"2021052713505415200_b15-1440219","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1939::AID-CNCR24>3.0.CO;2-Z","article-title":"Good outcome of children with acute myeloid leukemia and t(8;21) (q22;q22), even when associated with granulocytic sarcoma: a report from a single institution in Argentina","volume":"88","author":"Felice","year":"2000","journal-title":"Cancer"},{"key":"2021052713505415200_b16-1440219","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.leu.2402449","article-title":"Orbital granulocytic sarcoma and AML with poor prognosis in Turkish children","volume":"16","author":"Gozdasoglu","year":"2002","journal-title":"Leukemia"},{"key":"2021052713505415200_b17-1440219","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pbc.23201","article-title":"Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children\u2019s Oncology Group","volume":"58","author":"Johnston","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"2021052713505415200_b18-1440219","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.leukres.2010.01.009","article-title":"Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk Res"},{"key":"2021052713505415200_b19-1440219","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-2-42","article-title":"Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study","volume":"2","author":"Alexiev","year":"2007","journal-title":"Diagn Pathol"},{"key":"2021052713505415200_b20-1440219","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jcp.2008.063669","article-title":"Myeloid sarcoma of the small bowel associated with a CBFbeta\/MYH11 fusion and inv(16)(p13q22): a case report","volume":"62","author":"McKenna","year":"2009","journal-title":"J Clin Pathol"},{"key":"2021052713505415200_b21-1440219","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.leukres.2005.11.003","article-title":"Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB\/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature","volume":"30","author":"Fujieda","year":"2006","journal-title":"Leuk Res"},{"key":"2021052713505415200_b22-1440219","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"key":"2021052713505415200_b23-1440219","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021052713505415200_b24-1440219","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12185-009-0291-8","article-title":"Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience","volume":"89","author":"Vega-Ruiz","year":"2009","journal-title":"Int J Hematol"},{"key":"2021052713505415200_b25-1440219","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00277-013-1795-0","article-title":"Myeloid sarcoma preceding an acute promyelocytic leukaemia with neuromeningeal infiltration","volume":"93","author":"Pinan","year":"2014","journal-title":"Ann Hematol"},{"key":"2021052713505415200_b26-1440219","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1200\/JCO.2010.29.7424","article-title":"Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence","volume":"28","author":"Ochs","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021052713505415200_b27-1440219","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.leu.2404006","article-title":"Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy","volume":"20","author":"de Botton","year":"2006","journal-title":"Leukemia"},{"key":"2021052713505415200_b28-1440219","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3324\/haematol.10607","article-title":"Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia","volume":"92","author":"Cunha De Santis","year":"2007","journal-title":"Haematologica"},{"key":"2021052713505415200_b29-1440219","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1182\/blood-2009-02-204834","article-title":"Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome","volume":"114","author":"Luesink","year":"2009","journal-title":"Blood"},{"key":"2021052713505415200_b30-1440219","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cup.12231","article-title":"Aleukemic cutaneous myeloid sarcoma","volume":"40","author":"Aboutalebi","year":"2013","journal-title":"J Cutan Pathol"},{"key":"2021052713505415200_b31-1440219","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of FLT3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"2021052713505415200_b32-1440219","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021052713505415200_b33-1440219","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/leu.2012.156","article-title":"Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma","volume":"26","author":"Shimizu","year":"2012","journal-title":"Leukemia"},{"key":"2021052713505415200_b34-1440219","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1349-7006.2012.02324.x","article-title":"Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia","volume":"103","author":"Shimizu","year":"2012","journal-title":"Cancer Sci"},{"key":"2021052713505415200_b35-1440219","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3324\/haematol.2010.025890","article-title":"Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"95","author":"Clark","year":"2010","journal-title":"Haematologica"},{"key":"2021052713505415200_b36-1440219","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/1042819031000067503","article-title":"Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia","volume":"44","author":"Kottaridis","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"2021052713505415200_b37-1440219","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/modpathol.2012.88","article-title":"Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients","volume":"25","author":"Warren","year":"2012","journal-title":"Mod Pathol"},{"key":"2021052713505415200_b38-1440219","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"key":"2021052713505415200_b39-1440219","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ni.2255","article-title":"The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential","volume":"13","author":"Luc","year":"2012","journal-title":"Nat Immunol"},{"key":"2021052713505415200_b40-1440219","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000041035","article-title":"Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia","volume":"103","author":"Schmetzer","year":"2000","journal-title":"Acta Haematol"},{"key":"2021052713505415200_b41-1440219","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/sj.leu.2403981","article-title":"IgH\/TCR rearrangements are common in MLL translocated adult AML and suggest an early T\/myeloid or B\/myeloid maturation arrest, which correlates with the MLL partner","volume":"19","author":"Dupret","year":"2005","journal-title":"Leukemia"},{"key":"2021052713505415200_b42-1440219","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1080\/10428190600881231","article-title":"Megakaryoblastic differentiation of myeloid sarcoma in a patient with essential thrombocythemia","volume":"47","author":"Famoso","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"2021052713505415200_b43-1440219","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.leukres.2009.01.016","article-title":"Aleukemic bcr-abl positive granulocytic sarcoma","volume":"33","author":"Kuan","year":"2009","journal-title":"Leuk Res"},{"key":"2021052713505415200_b44-1440219","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2012.701739","article-title":"Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia","volume":"54","author":"Konoplev","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2021052713505415200_b45-1440219","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/PAS.0b013e31825dd4de","article-title":"Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases","volume":"36","author":"Vitte","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2021052713505415200_b46-1440219","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.leukres.2011.05.003","article-title":"Cutaneous manifestations in CMML: indication of disease acceleration or transformation to AML and review of the literature","volume":"36","author":"Mathew","year":"2012","journal-title":"Leuk Res"},{"key":"2021052713505415200_b47-1440219","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.3800768","article-title":"Benign extramedullary myeloid proliferations","volume":"20","author":"O\u2019Malley","year":"2007","journal-title":"Mod Pathol"},{"key":"2021052713505415200_b48-1440219","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13238-013-3057-2","article-title":"The evolving landscape in the therapy of acute myeloid leukemia","volume":"4","author":"Peloquin","year":"2013","journal-title":"Protein Cell"},{"key":"2021052713505415200_b49-1440219","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11899-014-0199-0","article-title":"Novel therapeutics in acute myeloid leukemia","volume":"9","author":"Sweet","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"2021052713505415200_b50-1440219","first-page":"58","article-title":"Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies","volume":"89","author":"Bueno","year":"2004","journal-title":"Haematologica"},{"key":"2021052713505415200_b51-1440219","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm\u2014morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2021052713505415200_b52-1440219","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico- immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2021052713505415200_b53-1440219","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury","year":"2002","journal-title":"Cancer"},{"key":"2021052713505415200_b54-1440219","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.leukres.2011.07.033","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review","volume":"36","author":"Rauh","year":"2012","journal-title":"Leuk Res"},{"key":"2021052713505415200_b55-1440219","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"2021052713505415200_b56-1440219","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","article-title":"TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow","volume":"88","author":"Alayed","year":"2013","journal-title":"Am J Hematol"},{"key":"2021052713505415200_b57-1440219","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"key":"2021052713505415200_b58-1440219","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2012-08-447599","article-title":"SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms","volume":"121","author":"Montes-Moreno","year":"2013","journal-title":"Blood"},{"key":"2021052713505415200_b59-1440219","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2013.01.027","article-title":"Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation","volume":"19","author":"Kharfan-Dabaja","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021052713505415200_b60-1440219","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cancergen.2013.07.002","article-title":"Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms","volume":"206","author":"Fu","year":"2013","journal-title":"Cancer Genet"},{"key":"2021052713505415200_b61-1440219","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","article-title":"CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique","volume":"99","author":"Leroux","year":"2002","journal-title":"Blood"},{"key":"2021052713505415200_b62-1440219","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2014.64","article-title":"Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-\u03baB pathway inhibition","volume":"28","author":"Sapienza","year":"2014","journal-title":"Leukemia"},{"key":"2021052713505415200_b63-1440219","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2010.08556.x","article-title":"TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm","volume":"153","author":"Jardin","year":"2011","journal-title":"Br J Haematol"},{"key":"2021052713505415200_b64-1440219","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Menezes","year":"2014","journal-title":"Leukemia"},{"key":"2021052713505415200_b65-1440219","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"121","author":"Roos-Weil","year":"2013","journal-title":"Blood"},{"key":"2021052713505415200_b66-1440219","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"2021052713505415200_b67-1440219","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.leukres.2009.09.006","article-title":"Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group","volume":"34","author":"Tsagarakis","year":"2010","journal-title":"Leuk Res"},{"key":"2021052713505415200_b68-1440219","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/2\/219\/38276227\/ajcpath144-0219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/144\/2\/219\/38276227\/ajcpath144-0219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T01:35:46Z","timestamp":1622165746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/144\/2\/219\/1766345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,8,1]]},"published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpo58ywibubesx","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,8,1]]},"published":{"date-parts":[[2015,8,1]]}}}